Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Oncogenesis|May 4, 2021
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic propertiesEleanor Star, Megan Stevens, Clare Gooding, et al.Biochimica Et Biophysica Acta|August 9, 2007
Translational regulation of human methionine synthase by upstream open reading framesBekir Col, Sebastian Oltean, Ruma BanerjeeGenes|November 25, 2023
Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer TherapeuticsLing Li, Jinxia Zheng, Sebastian OlteanClinical & Experimental Metastasis|June 5, 2008
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivoSebastian Oltean, Phillip G Febbo, Mariano A Garcia-BlancoNature Protocols|September 15, 2007
A protocol for imaging alternative splicing regulation in vivo using fluorescence reporters in transgenic miceVivian I Bonano, Sebastian Oltean, Mariano A Garcia-BlancoPharmacological Reviews|December 31, 2016
Pharmacology of Modulators of Alternative SplicingDavid O Bates, Jonathan C Morris, Sebastian Oltean, et al.RNA (New York, N.Y.)|October 28, 2006
Imaging the alternative silencing of FGFR2 exon IIIb in vivoVivian I Bonano, Sebastian Oltean, Robert M Brazas, et al.Biochemical Society Transactions|November 14, 2009
The anti-angiogenic isoforms of VEGF in health and diseaseYan Qiu, Coralie Hoareau-Aveilla, Sebastian Oltean, et al.Journal of Clinical Pathology|October 27, 2015
Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasionNicholas Bullock, Jonathan Potts, Andrew J Simpkin, et al.Science Signaling|November 23, 2017
Nuclear hyaluronidase 2 drives alternative splicing of <i>CD44</i> pre-mRNA to determine profibrotic or antifibrotic cell phenotypeAdam C Midgley, Sebastian Oltean, Vincent Hascall, et al.Pageof 6